SUPN Supernus Pharmaceuticals PE ratio, current and historical analysis
The current P/E ratio for Supernus Pharmaceuticals stock as of Oct 22, 2024 is 374.56. This is calculated based on the TTM EPS of $0.09 and the stock price of $33.71 per share.
SUPN PE ratio history
The average historical PE ratio of Supernus Pharmaceuticals for the last ten years is 77.6. The current price-to-earnings ratio of 374.56 is in line with the historical average. Analyzing the last ten years, SUPN's PE ratio reached its highest point in the Dec 2023 quarter at 1,447, when the price was $28.94 and the EPS was $0.02. The lowest point was recorded in the Mar 2020 quarter, when it reached 8.14 with a price of $17.99 and an EPS of $2.21.
Supernus Pharmaceuticals PE ratio by year
Maximum annual increase: 4,483.47% in 2023
Maximum annual decrease: -70.39% in 2016
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 1,447 | 4,483.47% |
| 2022 | 31.57 | 9.35% |
| 2021 | 28.87 | 176.53% |
| 2020 | 10.44 | -4.92% |
| 2019 | 10.98 | -29.62% |
| 2018 | 15.6 | -55.77% |
| 2017 | 35.27 | 157.07% |
| 2016 | 13.72 | -70.39% |
| 2015 | 46.34 | N/A |
| 2014 | N/A | N/A |
SUPN average PE ratio chart
The current PE ratio of SUPN is above its 3, 5 and 10-year averages.
SUPN PE vs peers
SUPN's PE ratio is above its peer stocks LLY and JNJ.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 10.89 | $399.34B |
| UTHR UNITED THERAPEUTICS Corp | 15.27 | $15.69B |
| ABT Abbott Laboratories | 36.8 | $203.59B |
| LLY ELI LILLY & Co | 110.8 | $858.26B |
| SUPN Supernus Pharmaceuticals Inc | 376.33 | $1.87B |
| BMY Bristol Myers Squibb Co | N/A | $107.57B |
Frequently asked questions
What is Supernus Pharmaceuticals's PE ratio?
The price to earnings ratio for SUPN stock as of Oct 22, 2024, stands at 374.56.
What is the 3-year average PE ratio for Supernus Pharmaceuticals (SUPN)?
Over the last 3 years, the average PE ratio for SUPN stock is 203.66.
What is the 5-year average PE ratio for Supernus Pharmaceuticals (SUPN)?
Over the last 5 years, the average PE ratio for SUPN stock is 118.39.
What is the highest PE ratio for SUPN?
The highest quarterly PE ratio in the last ten years has been 1,447 and it was in the Dec 2023 quarter.
How does the current PE ratio for SUPN compare to its historical average?
The current PE ratio of SUPN is 383% higher than the 10-year historical average.
Why is Supernus Pharmaceuticals's PE ratio so high?
SUPN's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
How is SUPN's PE ratio calculated (Supernus Pharmaceuticals PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Oct 22, 2024), Supernus Pharmaceuticals's share price is $33.71. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $0.09. Therefore, Supernus Pharmaceuticals's price to earnings ratio for today is 374.56. PE RATIO(374.56) = STOCK PRICE($33.71) / TTM EPS($0.09)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.